Flash talk video - IOI ECR Conference 2026 Winifred Maduko from the University of St Andrews shared her community-driven evaluation of AMR communication strategies in Nigeria. She was one of the winners of the best flash talk . 👉Watch their talk: https://www.youtube.com/watch?v=MY5qvGQKsHY

At our Early Career Researcher conference 2026, Michelle Yin from the University of Oxford presented a flash talk on conjugative pili and their potential to improve phage therapy against #AMR. 👉Watch her talk: https://www.youtube.com/watch?v=LCsM3vlNaG0

Last week, ITV News visited the IOI to learn about our work to protect antibiotics from antimicrobial resistance (#AMR). They spoke to surgeon David Sweetnam about the scale of the crisis, and Dr Alistair Farley about drug discovery at the IOI. Watch the segment here👉 https://ow.ly/ACim50ZbJGv

At our Early Career Researcher conference 2026, PhD student Alyaa Al-Tabtabai from King's College London shared her research on hydrogen sulphide gas and cold plasma as novel delivery systems for treating topical fungal infections. 👉Watch her talk: https://youtu.be/6Ac6nApwna0?si=3GySBu7ygyQzgZmk

IOI DPhil student Maria Nieto-Rosado is investigating how drug-resistant Klebsiella pneumoniae survive on surfaces like medical equipment and furniture in hospitals in LMIC countries . Her PhD research aims to update global infection prevention guidelines. Read more👉https://ow.ly/zzWi50Z9eV5

At our Early Career Researcher conference 2026, Sid Mookerjee from Brighton and Sussex Medical School shared insights into how AI and digital tools are being developed to optimise how we monitor and treat infections in real-time. 👉 Watch the full talk: https://ow.ly/8oKf50YT7ln

NEWS: New type of inhibitor could help tackle resistance against ‘last-resort’ antibiotics Read about this study from @ineosoxford.bsky.social 

Researchers from Ineos Oxford Institute for antimicrobial research (IOI) have discovered that cephalosporins, a widely used class of antibiotics, can block a key enzyme that SARS-CoV-2 needs to replicate - 120 compounds were investigated. 👉Read more: https://ow.ly/xGMm50Z73To

NEW: Researchers from @ineosoxford.bsky.social have identified a new class of molecule that could help protect ‘last-resort’ antibiotics from bacterial resistance, and reduce the amount of antibiotics needed to treat infections by up to 32 times ⬇️ https://bit.ly/4x2wMEo

Researchers from the IOI and Oxford AMR Network published four new studies related to antibiotic drug discovery in May, including investigations into the enzymes behind antimicrobial resistance, and the inhibitor drugs that stop them. Find out more👉https://www.ineosoxford.ox.ac.uk/research

At our Early Career Researcher Conference 2026, Dr Daire Cantillon from Liverpool School of Tropical Medicine discussed opportunities and barriers researchers face when navigating academic-industry collaborations. Watch the talk here 👉https://www.youtube.com/watch?v=Cc1JH8DBHRM

Scientists at the IOI and Oxford's Department of Pharmacology have identified a protein in MRSA bacteria that helps it develop antimicrobial resistance (#AMR). This new research will allow them to develop new ways of slow the development of AMR. Read more👉https://ow.ly/HbUR50Z2ABu

At our 2026 Early Career Researcher conference, Dr Melissa Haines, Clinical Lead at the Becky Mayer Centre for Phage Research, talked about the potential of phage therapy, and translating bench science into clinical treatments. 👉Watch the talk: https://www.youtube.com/watch?v=DxKreYk0I4o

Can resistant bacteria protect their neighbours from antibiotics? New review explore the concept of ’social resistance’ and if antibiotic-resistant enzymes can shield surrounding bacteria, that may not be resistant themselves. 👉Read the full article: https://ow.ly/Y7G450Z1vMg

IOI scientists have found a new inhibitor molecule to protect last-resort antibiotics from #AMR. This compound blocks antibiotic-degrading enzymes by trapping water around inside them, reducing the amount of antibiotic needed to treat infections by up to 32x. Read more👉https://ow.ly/Cees50Z15BE#AMR

In March, IOI DPhil students took part in the Curiosity Cube programme, helping over 450 school children explore key microbiology concepts like enzymes, DNA, and bacteria through interactive learning experiences. Read more about outreach at the IOI👉https://ow.ly/zSNv50YSkPh #SPARKCuriosity #AMR

IOI researchers have found that SmTetX - a recently discovered enzyme which was thought to degrade tetracycline antibiotics - may not contribute to #AMR. Clarifying which enzymes cause AMR is crucial for global tracking, and finding new drug targets. Read more👉 https://ow.ly/JJO350YZ1Ht

Speaker video - IOI ECR Conference 2026 Dr Norman van Rhijn from Manchester University delivered a talk on how climate change is directly influencing fungal pathogens and the rise of antifungal resistance. 👉Watch their full talk: https://www.youtube.com/watch?v=oGQECiMxqmI

In LMICs, microbiological lab tests can be expensive to access. Oxford DPhil Forhad Chowdhury tested a new approach using procalcitonin, a biomarker that shows when infections have cleared. With this, course length could be cut down by around 3 days. 🔗https://ow.ly/acyj50YRNmM

Dr Jeannine Hess from The Francis Crick Institute & King's College London presented her work at our Early Career Researcher conference, on using metal complexes as innovative chemical tools for antimicrobial drug discovery. 👉Watch the talk: https://www.youtube.com/watch?v=BOx-hFAiuWw #IOIECR26

As antibiotic resistance grows, scientists are turning to bacteriophages: viruses that target harmful bacteria without wiping out beneficial microbes. Discover more about these incredible microscopic predators via @ConversationUK: bit.ly/3OG5nHd

Clean hands save lives. 🤝 Infection prevention and control action, including #HandHygiene, can reduce the risk of health care-associated infections by up to 70%. Let’s stop the spread of germs and reduce avoidable infections!

#MicrobiologyMonday: Reusing treated wastewater for irrigation could ease water shortages—but spore‑forming pathogens like C. diff can survive treatment & persist in soils, raising concerns about crop contamination & antibiotic resistance. #AppEnvMicro: asm.social/2VC

Millions globally are affected by wounds with biofilms - slimy layers that defend bacteria from antibiotics. Victor Choi (Department of Engineering Science, University of Oxford) uses ultrasound to break biofilms, and the IOI helped him to test his work beyond the lab. 🔗https://ow.ly/QPUO50YRCnn

Speaker video - IOI ECR Conference 2026 Dr Jennifer Schneider, CEO of Centauri Therapeutics delivered the keynote address at our ECR conference on “Doing the work to improve outcomes for those with difficult to treat infections”. 👉 Watch full talk: https://ow.ly/AVQk50YRBMQ

1 in 3 infections in some LMICs show signs of #AMR, but most data still comes from high-income countries. That's why BALANCE, led by Dr Refath Farzana, is gathering data from >67,000 patients worldwide, providing a global view of resistance. Read more on our website👉https://ow.ly/IQrn50YQBb7

IOI researchers and collaborators presented 45+ posters & talks at the ESCMID Global conference in Munich - spanning bacteriophages, drug discovery & more. Huge thank you to everyone who represented the IOI this year👏. Explore all topics on our website 👉https://ow.ly/TKk350YOA6n

Last year, 10 early-career researchers from across the University of Oxford received a grant from the IOI and Oxford AMR Network, helping them build strong partnerships, share their work worldwide, and learn new skills to shape their research. Read more about their work ➡️https://ow.ly/Mnnk50YOp0C

EVENT: Oxford AMR Network on translation and commercialisation Oxford researchers working on antimicrobial resistance are invited to hear from Oxford Science Enterprises and Oxford University Innovation, followed by networking. 📅 Tuesday 12 May, LaMB 👉 https://tinyurl.com/3nbz76jx

Antifungal resistance leads to >3.8 million deaths each year. To address this global threat, the IOI has established a new antifungal drug discovery programme, led by Dr Xuefei (Fei) Chen, to uncover new antifungal agents and treatments. Find out more 👉https://ow.ly/SiAV50YMst9

Ineos Oxford Institute for antimicrobial research (IOI) at ESCMID Global 2026: Munich, Germany Researchers from the IOI are presenting over 45 posters and talks at this year's ESCMID conference. 👉Explore the schedule of IOI presentations: https://ow.ly/i5JV50YIiLr #ESCMID

Two global #AMR studies run by the IOI have finished collecting data, gathering 24,000 samples from 135,000 patients worldwide. Analysis of these samples will continue in the UK, producing data that improves treatment, guide antibiotic use, and save lives. Read more 👉 https://ow.ly/lnV350Yyaym#AMR

The Sheppard lab rocking at #MicroBio26 conference (Microbiology society annual conference 2026) at Belfast, UK Come, find us, talk to us ! @microbiologysociety.org @ineosoxford.bsky.social @ox.ac.uk

In February, the IOI hosted a scientific dissemination and data analysis workshop in Nairobi, bringing together collaborators from many African countries for discussions on #AMR, and to share how research shapes clinical practice and local engagement. Read more👉https://ow.ly/1BUK50YH36C#AMR

At the 2026 IOI ECR conference >200 researchers from a range of disciplines came together in Oxford to share their #AMR work. Dr Katy Thomson, scientific lead at the IOI, presented findings from the global surveillance study, BARNARDS. Watch the full recording here➡️ youtu.be/oZ7upw9xPnI?...

#ICYMI IOI researchers traced infections of Campylobacter, the no. 1 bacterial cause of diarrhoeal disease, back to their source — estimating that 80% came from poultry. They recommend improved animal welfare on farms to control poultry-related infections. Read more 👉 https://ow.ly/g0BG50YACs5#ICYMI

#ICYMI IOI researchers have worked with Nigerian clinicians to gather >1,700 samples from 90 mother-baby pairs for one year after birth. They will study how environmental factors affect the early-life bacterial and antibiotic exposures of Nigerian infants. Read more 👉https://ow.ly/l0kq50YAGit

IOI’s Dr Alistair Farley speaks to BBC Discovery show about the development of new drugs and combination therapies to tackle antimicrobial resistance (#AMR). He discusses his work finding new inhibitor drugs to target resistance mechanisms in bacteria. Listen here:https://ow.ly/81cu50YB4bA

Early career researchers are central to tackling #AMR, and we were delighted to host 200+ at our ECR conference last week. As well as the speakers and participants, we would like to thank our ECR working group for their support. Missed it? We’ll be sharing the talks soon https://ow.ly/AeZL50Yyy0x#AMR

Today is #WorldTBDay ~500,000 people each year are infected with drug-resistant TB, and we need new drugs to fight this global threat. At the IOI, chemists, biologists, clinicians, vaccinologists and health sociologists are working together to develop new therapies for TB.

IOI’s Dr Kirsty Sands speaks to BBC Discovery about the global impact of antimicrobial resistance (AMR). She highlights concerning findings that newborn babies in West Africa are already carrying antibiotic-resistant bacteria at birth. Listen here: https://www.bbc.co.uk/sounds/play/w3ct6sxh

The #IOIECR26 conference has officially begun! A huge thank you to everybody attending today, especially to all of our speakers and poster presenters sharing their #AMR research!

Researchers at the IOI developed a new method to pinpoint the "hidden" gene networks driving MRSA resistance. This AI-driven approach is 76% more accurate than standard models, it can establishes a predictive model for how different superbugs adapt over time. 👆Read more: https://ow.ly/3iY350YsQlm

IOI and Oxford Biology scientists estimate ~80% of Campylobacter infections are linked to poultry, and many are drug-resistant. Campylobacter is the #1 bacterial cause of food poisoning. Cooking chicken well, and practicing good hygiene, prevents infection. Read more👉 https://ow.ly/9ReF50Yty9O

📣We're pleased to announce our flash talk speakers for the 2026 IOI Early Career Researcher conference! #IOIECR26 🎓Join us in Oxford on 20 March to find out about their fantastic range of #AMR research Read more➡️ https://www.ineosoxford.ox.ac.uk/event/ioi-early-career-researcher-conference-2026#IOIECR26

The IOI has launched the Campylobacter Control Campaign in The Gambia. Led by Prof Sam Sheppard, a team of researchers from 19 countries will work together to develop vaccines for livestock to target campylobacter- the most common bacterial cause of diarrhoea. 👆Read more: https://ow.ly/X8uM50YtmPe

📣 Speaker alert! #IOIECR26 Our final keynote speaker for the 2026 ECR conference is the IOI's director, Prof Kevin Pethe. 💊Prof Pethe’s talk will focus on his work at the intersection of research and industry. Read more about the ECR conference on our website ➡️https://ow.ly/4jfZ50Yrj0s

We kick-off the Campylobacter Control Campaign meeting with partners from @lshtm.bsky.social, @biology.ox.ac.uk, @ineosoxford.bsky.social, alongside collaborators from Côte d’Ivoire, #Nigeria, #Egypt, #Ghana & #BurkinaFaso to finalise a genomic sampling framework to support future vaccine designs.

📣 Speaker alert! #IOIECR26 Dr Katy Thomson from the IOI will present at our 2026 Early Career Researcher conference, sharing findings from our global neonatal sepsis and #AMR surveillance study, BARNARDS. Find out more about the ECR conference➡️ https://ow.ly/CmUw50YrjR7

Dr Dorian Muntean built on his doctoral work on β-lactam antibiotics for SARS-CoV-2 to challenge current thinking on antimicrobial resistance, showing how antibiotic inhibitors bind to microbial enzyme targets in ways that could guide new drug development. 👆Read more : https://ow.ly/Ns6450YrbR2